Director Clinical Development

Scorpion Therapeutics; Gaithersburg (MD); Hybrid; USD 220,000 - 360,000; Full time

Job summary

Scorpion Therapeutics is seeking a Lead in clinical development to oversee oncology programs, including immuno-oncology initiatives, across early to late-phase trials. The role emphasizes designing innovative trial protocols, shaping development plans, and strategic biomarker integration.

You will manage CRO relationships, provide medical monitoring, and contribute to regulatory submissions and publications, while building external relationships with key opinion leaders and regulatory bodies.

Qualifications

• MD or MD/PhD with research training and proven achievement in oncology therapy development.
• Minimum 3 years of clinical drug development experience, including early-phase trials.
• At least 2 years as a medical monitor in biotech/pharma or CRO.

Responsibilities

• Lead clinical development strategy and medical oversight for oncology programs.
• Design innovative trial protocols and development plans.
• Manage CRO relationships, provide medical monitoring.
• Contribute to regulatory submissions and publications.
• Build external relationships with key opinion leaders and regulators.
• Provide strategic input on biomarker and trial design innovation.

Skills

Pharmacokinetics

Biomarkers

Regulatory knowledge

Clinical science

Stakeholder engagement

Leadership

Education

MD or MD/PhD

Job description

Role

Lead clinical development strategy and medical oversight for oncology programs, focusing on immuno-oncology. Responsibilities include designing innovative trial protocols, shaping development plans, managing CRO relationships, providing medical monitoring, and contributing to regulatory submissions and publications. The role involves building external relationships with key opinion leaders, supporting collaboration efforts, and participating in regulatory interactions. It also includes strategic input on biomarker and trial design innovation.

Qualifications

MD or MD/PhD with research training and proven achievement in oncology therapy development; minimum 3 years of clinical drug development experience, including early-phase trials; at least 2 years as a medical monitor in biotech/pharma or CRO.

Skills

strong understanding of pharmacokinetics, biomarkers, regulatory requirements, and clinical science; excellent stakeholder engagement, communication, and leadership abilities.

High-Value

oncology, immuno-oncology, early to late-phase clinical trials, global regulatory interactions, biomarker strategies, and cross-functional collaboration.

Work Setup

flexible US or UK locations; specific arrangements not detailed, likely hybrid or remote.